Naringin time-dependently lowers hepatic cholesterol biosynthesis and plasma cholesterol in rats fed high-fat and high-cholesterol diet

Journal of Medicinal Food

Volumn 9, Issue 4, 2006, Pages 582-586

  Kim, So Yeon ^a   Kim, Hye Jin ^b   Lee, Mi Kyung ^c   Jeon, Seon Min ^b   Do, Gyeong Min ^b   Kwon, Eun Young ^b   Cho, Yun Young ^b   Kim, Dong Ju ^b   Jeong, Kyu Shik ^c   Park, Yong Bok ^b   Ha, Tae Yul ^d   Choi, Myung Sook ^b  

^a Seoul National University Bundang Hospital   (South Korea)

^b Kyungpook National University   (South Korea)

^c Sunchon National University   (South Korea)

^d Korea Food Research Institute   (South Korea)

Author keywords

3 hydroxy 3 methylglutaryl coenzyme A reductase; Acyl coenzyme A:cholesterol acyltransferase; High fat and high cholesterol diet; Naringin; Rat

Indexed keywords

3 HYDROXY 3 METHYLGLUTARYL COENZYME A; AURANTIIN; CHOLESTEROL; CHOLESTEROL ACYLTRANSFERASE; FLAVONOID; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ARTICLE; ATHEROGENESIS; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL DIET; CHOLESTEROL LIVER LEVEL; CHOLESTEROL SYNTHESIS; CONTROLLED STUDY; DIET SUPPLEMENTATION; ENZYME ACTIVITY; HYPOLIPEMIA; LIPID DIET; NONHUMAN; PRIORITY JOURNAL; RAT; TRIACYLGLYCEROL BLOOD LEVEL;

ANIMALIA; RATTUS;

EID: 33846196243     PISSN: 1096620X     EISSN: None     Source Type: Journal    
DOI: 10.1089/jmf.2006.9.582     Document Type: Article

References (41)

1. Wald NJ, Law MR: Serum cholesterol and ischaemic heart disease. Atherosclerosis 1995;118(Suppl):S1-S5.
2. Dietschy JM, Turley SD, Spady DK: Role of liver in the maintenance of cholesterol and low density lipopretein homeostasis in different abnormal species, including human. J Lipid Res 1993;34:1637-1659.
3. Albert AW, Chen J, Kuron G, Hunt V, Huff J, Hoffman C, Rothrock J, Lopez M, Joshua H, Harris E, Patchett A, Monaghan R, Currie S, Stapley E, Albers-Shonberg E, Hensens O, Hirshfield J, Hoogsteen K, Liesch J, Springer J: Mevinolin: a highly potent competitive inhibitor of hydroxymethylglutaryl- coenzyme A reductase and a cholesterol-lowering agent. Proc Natl Acad Sci USA 1980;77:1957-1961.
4. Suckling KE, Stange EF: Role of acyl-CoA cholesterol acyltransferase in cellular cholesterol metabolism. J Lipid Res 1985; 26:647-671.
5. Hertog MG, Feskens EJ, Hollman PC, Katan MB, Kromhout D: Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen Elderly Study. Lancet 1993;342:1007-1011.
6. Lanningham-Foster L, Chen C, Chance DS, Loo G: Grape extract inhibits lipid peroxidation of human low density lipoprotein. Biol Pharm Bull 1995;18:1347-1351.
7. Hollman PC, van Trijp JM, Mengelers MJ, de Vries JH, Katan MB: Bioavailability of the dietary antioxidant flavonol quercetin in man. Cancer Lett 1997;114:139-140.
8. Di PT, Auteri A: Action of S5682 on the conplement system. In vitro and in vivo study. Int Angiol 1988;7:11-15.
9. Kato R, Nakadate T, Yamamoto S, Sugimura T: Inhibition of 12-O-tetradecanoylphorbol-13-acetate-induced tumor promotion and ornithine decarboxylase activity by quercetin: possible involvement of lipoxygenase inhibition. Carcinogenesis 1983;4:1301-1305.
10. Wattenberg LW: Chemoprevention of cancer. Cancer Res 1985; 45:1-8.
11. Aboobaker VS, Balgi AD, Bhattacharya RK: In vivo effect of dietary factors on the molecular action of aflatoxin B: role of nonnutrient phenolic compounds in the catalytic activity of liver fraction. In Vivo 1994;8:1095-1098.
12. Buening MK, Chang RL, Huang MT, Fortner JG, Wood AW, Conney AH: Activation and inhibition of benzo(a)pyrene and aflatoxin B1 metabolism in human liver microsomes by naturally occurring flavonoids. Cancer Res 1981;41:67-72.
13. Monfort MT, Trovato A, Kirjavainen S, Forestieri AM, Galati EM, Lo Curto RB: Biological effects of hesperidin, a citrus flavonoid. (Note II): Hypolipidemia activity on experimental hypercholesterolemia in rat. Farmaco 1995;50:595-599.
14. Tsai SH, Lin-Shiau SY, Lin JK: Suppression of nitric oxide synthase and the down-regulation of the NfkappaB in macrophages by resveratrol. Br J Pharmacol 1999;126:673-680.
15. Le Marchand L, Murphy SP, Hankin JH, Wilkens LR, Kolonel LN: Intake of flavonoids and lung cancer. J Natl Cancer Inst 2000;92:154-160.
16. So FA, Guthrie N, Chambers AF, Moussa M, Carroll KK: Inhibition of human breast cancer cell proliferation and delay of mammary tumorigenesis by flavonoids and citrus juices. Nutr Cancer 1996;26:167-181.
17. Bok SH, Shin YW, Bae KH, Jeong TS, Kwon YK, Park YB, Choi MS: Effect of naringin and lovatatin in plasma and hepatic lipids in high-fat and high-cholesterol fed rats. Nutr Res 2000;20: 1007-1015.
18. Lee SH, Jeong TS, Park YB, Kwon YK, Choi MS, Bok SH: Plasma and hepatic cholesterol and hepatic activities of 3-hydroxy-3-methyl-glutaryl-CoA reductase and acyl CoA:cholesterol transferase are lower in rats fed citrus peel extract or a mixture of citrus bioflavonoids. J Nutr 1999;129:1182-1185.
19. Shin YW, Bok SH, Jeong TS, Bae KH, Jeong NH, Choi MS, Lee SH, Park YB: Hypocholesterolemic effects of naringin associated with hepatic cholesterol regulating enzyme changes in rats. Int J Vitam Nutr Res 1999;69;341-347.
20. American Institute of Nutrition: Report of the American Institute of Nutrition. Ad Hoc Committee on Standards for Nutritional Studies. J Nutr 1977;107:1340-1348.
21. American Institute of Nutrition: Report of Ad Hoc Committee on Standards for Nutritional Studies. J Nutr 1980;110:1717-1726.
22. Allain CC, Poon LS, Chan CS, Richmond W, Fu PC: Enzymatic determination of total serum cholesterol. Clin Chem 1974;20: 470-475.
23. Warnick GR, Albers JJ: A comprehensive evaluation of the heparin-manganease precipitation procedure for estimating a high density lipoprotein cholesterol. J Lipid Res 1978;19:65-76.
24. McGowan MW, Artiss JD, Strandbergh DR, Zak B: A peroxidase-coupled method for the colorimetric determination of serum triglycerides. Clin Chem 1983;29:538-542.
25. Folch J, Lees M, Sloan-Stanley GH: A simple method for isolation and purification of total lipids from animal tissues. J Biol Chem 1957;226:497-509.
26. Hulcher FH, Oleson WH: Simplified spectrophotometric assay for microsomal 3-hydroxy-3-methylglutaryl CoA reductase by measurement of coenzyme A. J Lipid Res 1973;14:625-631.
27. Shapiro DJ, Nordstrom JL, Mitschelen JJ, Rodwell VW, Schimke RT: Micro assay for 3-hydroxy-3-methylglutaryl-CoA reductase in rat liver and L-cell fibroblasts. Biochim Biophys Acta 1974;370:369-377.
28. Erickson SK, Schrewsbery MA, Brooks C, Meyer DJ: Rat liver acyl-coenzyme Axholesterol acyltransferase: its regulation in vivo and some of its properties in vitro. J Lipid Res 1980;21:930-941.
29. Gillies PJ, Rathgeb KA, Perri MA, Robinson CS: Regulation of acyl-CoA:cholesterol acyltransferase activity in normal and atherosclerotic rabbit aortas: role of a cholesterol substrate pool. Exp Mol Pathol 1986;44:329-339.
30. Jeon SM, Bok SH, Jang MK, Lee MK, Nam TK, Park YB, Rhee SJ, Choi MS: Antioxidative activity of naringin and lovastatin in high cholesterol-fed rabbits. Life Sci 2001;69:2855-2866.
31. Choi MS, Do KM, Park YB, Jeon SM, Jeong TS, Lee YK, Lee MK, Bok SH: Effect of naringin supplementation on cholesterol metabolism and antioxidant status in rats fed high cholesterol with different levels of vitamin E. Ann Nutr Metab 2001;45:193-201.
32. Bjorkhem I: Mechanism of bile acid biosynthesis in mammalian liver. In: New Comprehensive Biochemistry (Danielsson H, Sjovall J, eds.), Elsevier, Amsterdam, 1985, pp. 231-278.
33. Ness GC, Bales S, Lopez D, Zhao Z: Regulation of 3-hydroxy-3-methyl glutaryl coenzyme A reductase gene expression by sterols and nonsterols in rat liver. Arch Biochem Biophys 1994;308:420-425.
34. Xu G, Shineider BL, Shefer S, Nguyen LB, Batta AK, Tint GS, Arres M, Thevananther S, Ma L, Stengelin S, Kramer W, Greenblatt D, Pcolinsky M, Salen G: Ileal bile acid transport regulates bile acid pool, synthesis, and plasma cholesterol levels differently in cholesterol-fed rats and rabbits. J Lipid Res 2000;41:298-304.
35. Suckling KE, Stange EF: Role of acyl-CoA cholesterol acyltransferase in cellular cholesterol metabolism. J Lipid Res 1985;26:647-671.
36. Brown MS, Goldstein JL: A receptor mediated pathway for cholesterol homeostasis. Science 1986;232:34-47.
37. Kannel WB, Dawber TR, Kagan A, Rovostski N, Strokes J: Factors of risk in the development of coronary heart disease-six year follow-up experience: the Framingham study. Ann Intern Med 1961;55:33-50.
38. Frick MH, Elo O, Happa K, Heinonen OP, Heinsalmi P, Helo P, Huttunen JK, Kaitaniemi P, Koskinen P, Manninen V: Helsinki Heart Study: primary prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease. N Engl J Med 1987;317:1237-1245.
39. Field FJ, Cooper AD, Erickson SK: Regulation of rabbit intestinal acylcoenzyme A:cholesterol acyltransferase in vivo and in vitro. Gastroenterology 1982;83:873-880.
40. Jeon SM, Park YB, Choi MS: Antihypercholesterolemic property of naringin alters plasma and tissue lipids, cholesterol-regulating enzymes, fecal sterols and tissue morphology in rabbits. Clin Nutr 2004;23:1025-1034.
41. Kurowska EM, Manthey JA: Hypolipidemic effects and absorption of citrus polymethoxylated flavones in hamsters with diet-induced hypercholesterolemia. J Agric Food Chem 2004;52:2879-2886.